Daiwa Securities Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-179
| Closed | -$17K | – | 1448 |
|
|
2021
Q4 | $17K | Sell |
179
-30
| -14% | -$1.98K | ﹤0.01% | 1126 |
|
|
2021
Q3 | $12K | Buy |
209
+90
| +76% | +$5.32K | ﹤0.01% | 1125 |
|
|
2021
Q2 | $8K | Hold |
119
| – | – | ﹤0.01% | 1055 |
|
|
2021
Q1 | $8K | Buy |
119
+10
| +9% | +$769 | ﹤0.01% | 1054 |
|
|
2020
Q4 | $8K | Sell |
109
-209
| -66% | -$15.7K | ﹤0.01% | 1032 |
|
|
2020
Q3 | $24K | Buy |
318
+35
| +12% | +$2.33K | ﹤0.01% | 979 |
|
|
2020
Q2 | $12K | Hold |
283
| – | – | ﹤0.01% | 1060 |
|
|
2020
Q1 | $12K | Hold |
283
| – | – | ﹤0.01% | 1051 |
|
|
2019
Q4 | $13K | Sell |
283
-32
| -10% | -$1.51K | ﹤0.01% | 1042 |
|
|
2019
Q3 | $14K | Hold |
315
| – | – | ﹤0.01% | 1017 |
|
|
2019
Q2 | $18K | Hold |
315
| – | – | ﹤0.01% | 1019 |
|
|
2019
Q1 | $14K | Sell |
315
-52
| -14% | -$2.38K | ﹤0.01% | 1015 |
|
|
2018
Q4 | $14K | Buy |
367
+150
| +69% | +$5.89K | ﹤0.01% | 985 |
|
|
2018
Q3 | $10K | Hold |
217
| – | – | ﹤0.01% | 1041 |
|
|
2018
Q2 | $9K | Hold |
217
| – | – | ﹤0.01% | 1061 |
|
|
2018
Q1 | $9K | Buy |
+217
| New | +$8.44K | ﹤0.01% | 1041 |
|
Daiwa Securities Group's ARNA Position: Q1 2022 in Review
Daiwa Securities Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 179 shares — an estimated $17K sold.
Daiwa Securities Group first reported a position in ARNA in Q1 2018 and held it in 16 quarters. The position peaked at $24K in Q3 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Daiwa Securities Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Daiwa Securities Group sold 179 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $17K.
- Daiwa Securities Group first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 16 quarters.
- Daiwa Securities Group's Arena Pharmaceuticals Inc position peaked at $24K in Q3 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Daiwa Securities Group's 13F filing for Q1 2022, filed 29 Apr 2022.